WuXi Biologics Leads in Water Stewardship on World Water Day Celebration

WuXi Biologics Champions Water Stewardship on World Water Day

On March 21, 2026, WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), marked World Water Day by reaffirming its commitment to sustainability and responsible resource management. With a focus on effective water use practices, the company aims to lessen its environmental footprint while aligning with global sustainability goals.

For three consecutive years, WuXi Biologics has secured a spot on the CDP Water Security "A List," recognizing its industry-leading performance in environmental stewardship and transparency. This accolade highlights the company’s relentless dedication to sustainable water management. By establishing robust water management frameworks, it endeavors to meet its water consumption targets while fulfilling stakeholders’ sustainability expectations.

Significant Progress in Water Management

Aligned with the United Nations Sustainable Development Goal 6, which aims to ensure availability and sustainable management of water and sanitation for all, WuXi Biologics has made significant strides in improving water efficiency. The company’s target was to decrease water consumption intensity by 30% by 2025, setting the year 2019 as the baseline. By the end of 2025, WuXi Biologics proudly announced that it had successfully met this ambitious target, reflecting its ongoing efforts to improve water efficiency and bolster its sustainability credentials.

To further enhance its water management, WuXi Biologics launched the Water Excellence Stewardship (WES) program in 2024. This initiative encompasses various aspects of water management, including governance, quality, and personal hygiene standards, ensuring each operational site can evaluate its sustainable water management practices. By the conclusion of 2025, the WES program was fully implemented across 10 of WuXi Biologics' global sites, fostering a culture of sustainability within the organization.

Leadership’s Vision on Sustainability

Dr. Chris Chen, the CEO of WuXi Biologics and Chairman of the ESG Committee, emphasized the critical importance of natural resources for human well-being, particularly in the biopharmaceutical industry. He stated, “WuXi Biologics is committed to protecting the environment through responsible operations that promote exemplary water stewardship, ensuring universal access to water and sanitation.” Dr. Chen noted that as a global leader in Green CRDMO, the company continually aims to deliver excellence in Environmental, Social, and Governance (ESG) practices. This commitment enables partners worldwide to fulfill their own sustainability objectives.

WuXi Biologics has actively engaged in the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI), pushing for sustainability across its operations and earning numerous accolades for its efforts. The company’s recognition extends beyond the CDP's Water Security A List; it has also been acknowledged for its climate initiatives, receiving an A rating in the CDP Supplier Engagement Assessment, among other honors, including an MSCI AAA rating and a Platinum Medal from EcoVadis.

A Future of Sustainable Innovation

With over 12,000 skilled employees across key locations including China, the United States, Ireland, Germany, and Singapore, WuXi Biologics remains devoted to driving innovations in green technology. This focus on sustainability not only supports the development of biologics from concept to commercialization but also aligns with the company's strategy to provide end-to-end Green CRDMO solutions globally. As of December 31, 2025, WuXi Biologics was backing 945 integrated client projects, showcasing its significant role in the biopharmaceutical sector.

WuXi Biologics believes that sustainability is a cornerstone of long-term business growth, fostering partnerships to create shared value in the industry. Through the WES program and other initiatives, it continues to promote responsible practices across its value chain, further enhancing its position as a leader in the biopharmaceutical landscape.

For more information on WuXi Biologics and its commitment to sustainability, visit WuXi Biologics.